🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Omalizumab will be given as add-on treatment to optimized asthma therapy in...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT00264849
Treatments Being Tested
This was a cross-over, polysomnography (PSG) study to test the safety, tole...
Status
Completed
Location
Multiple Locations
Start Date
2009-11-30
Trial ID
NCT01021852
Treatments Being Tested
The aim of this study was to determine whether long-term (≥ 6 months at the...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-03-27
Trial ID
NCT00303498
Treatments Being Tested
Children with cerebral palsy (CP) present a variety of motor impairments an...
Status
Not Yet Recruiting
Location
Hôpital Raymond Poincaré - Service Neurologie Pédiatrique Médecine Physique et Réadaptation
Start Date
2026-03
Trial ID
NCT07301593
Treatments Being Tested
Veterans are at higher risk than non-Veterans of falling ill with amyotroph...
Status
Recruiting
Location
James J. Peters VA Medical Center, Bronx, NY
Start Date
2024-04-01
Trial ID
NCT06172621
Treatments Being Tested
This is a multicentre, randomised, double-blind, parallel group study in As...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-10
Trial ID
NCT02058368
Sixty physically active patients (aged 18-45) with chronic mid-portion Achi...
Status
Completed
Location
Sports Surgery Clinic
Start Date
2020-01-29
Trial ID
NCT04384874
Treatments Being Tested
The purpose of this study is to develop a Question Prompt List (QPL) about ...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2008-04
Trial ID
NCT00662324
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of Relugolix (TAK-385...
Status
Completed
Location
Multiple Locations
Start Date
2016-03-05
Trial ID
NCT02655237
Treatments Being Tested
Background: Anetumab ravtansine is a new drug. It kills cancer cells that ...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2016-07-19
Trial ID
NCT02839681
Treatments Being Tested